Serum bilirubin after acute ischemic stroke is associated with stroke severity

Current Neurovascular Research

Volumn 9, Issue 2, 2012, Pages 128-132

  Luo, Yun ^a   Li, Jing Wei ^a   Lu, Zheng Juan ^a   Wang, Chong ^a   Guan, De Ning ^a   Xu, Yun ^a,b  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Acute ischemic stroke; Bilirubin; Severity

Indexed keywords

BILIRUBIN; BILIRUBIN GLUCURONIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD SAMPLING; BRAIN ISCHEMIA; CLINICAL ASSESSMENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK; RISK FACTOR;

EID: 84860720263     PISSN: 15672026     EISSN: 18755739     Source Type: Journal    
DOI: 10.2174/156720212800410876     Document Type: Article

References (27)

1. Herishanu Y, Abramsky O, Lavy S. Hyperbilirubinaemia in acute ischaemic stroke. J Neurol Sci 1971; 14(4): 417-420.
2. Kawamura K, Ishikawa K, Wada Y, et al. Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction. Arterioscler Thromb Vasc Biol 2005; 25(1): 155-160. (Pubitemid 40054269)
3. Baranano DE, Rao M, Ferris CD, Snyder SH. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA 2002; 99(25): 16093-16098. (Pubitemid 35462754)
4. Doré S, Takahashi M, Ferris CD, et al. Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc Natl Acad Sci USA 1999; 96(5): 2445-2450. (Pubitemid 29117935)
5. Sedlak TW, Saleh M, Higginson DS, Paul BD, Juluri KR, Snyder SH. Bilirubin and glutathione have complementary antioxidant and cytoprotective roles. Proc Natl Acad Sci USA 2009; 106(13): 5171-5176.
6. Franchini M, Targher G, Lippi G. Serum bilirubin levels and cardiovascular disease risk: a Janus Bifrons? Adv Clin Chem 2010; 50: 47-63. [Pubmed: 20521440].
7. Kimm H, Yun JE, Jo J, Jee SH. Low serum bilirubin level as an independent predictor of stroke incidence: a prospective study in Korean men and women. Stroke 2009; 40(11): 3422-3427.
8. Ishizaka N, Ishizaka Y, Takahashi E, Yamakado M, Hashimoto H. High serum bilirubin level is inversely associated with the presence of carotid plaque. Stroke. 2001; 32(2): 580-583.
9. Perlstein TS, Pande RL, Creager MA, Weuve J, Beckman JA. Serum total bilirubin level, prevalent stroke, and stroke outcomes: NHANES 1999-2004. Am J Med 2008; 121(9): 781-788.
10. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235(4792): 1043-1046. (Pubitemid 17049750)
11. Pineda S, Bang OY, Saver JL, et al. Association of serum bilirubin with ischemic stroke outcomes. J Stroke Cerebrovasc Dis 2008; 17(3): 147-152. (Pubitemid 351626614)
12. Dohi K, Mochizuki Y, Satoh K, et al. Transient elevation of serum bilirubin (a heme oxygenase-1 metabolite) level in hemorrhagic stroke: Bilirubin is a marker of oxidant stress. Acta Neurochir Suppl 2003; 86: 247-249.
13. Hidalgo FJ, Zamora R, Dillard CJ, Tappel AL. Can serum bilirubin be an index of in vivo oxidative stress? Med Hypotheses 1990; 33(3): 207-211. (Pubitemid 20383064)
14. Foell RB, Silver B, Merino JG, et al. Effects of thrombolysis for acute stroke in patients with pre-existing disability. CMAJ 2003; 169(3): 193-197. (Pubitemid 37011561)
15. Clark WM, Williams BJ, Selzer KA, Zweifler RM, Sabounjian LA, Gammans RE. A randomized efficacy trial of citicoline in patients with acute ischemic stroke. Stroke 1999; 30(12): 2592-2597.
16. Briggs DE, Felberg RA, Malkoff MD, Bratina P, Grotta JC. Should mild or moderate stroke patients be admitted to an intensive care unit? Stroke 2001; 32(4): 871-876. (Pubitemid 32285152)
17. Chen SD, Yang DI, Lin TK, Shaw FZ, Liou CW, Chuang YC. Roles of Oxidative Stress, Apoptosis, PGC-1a and Mitochondrial Biogenesis in Cerebral Ischemia. Int J Mol Sci 2011; 12(10): 7199-7215.
18. Chen SD, Lee JM, Yang DI, Nassief A, Hsu CY. Combination therapy for ischemic stroke: potential of neuroprotectants plus thrombolytics. Am J Cardiovasc Drugs 2002; 2(5): 303-313. (Pubitemid 35214933)
19. Niizuma K, Endo H, Chan PH. Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survival. J Neurochem 2009; 109 suppl 1: 133-138.
20. Chen SD, Lin TK, Yang DI, et al. Protective effects of peroxisome proliferator-activated receptors gamma coactivator-1alpha against neuronal cell death in the hippocampal CA1 subfield after transient global ischemia. J Neurosci Res 2010; 88(3): 605-613.
21. Leinonen JS, Ahonen JP, Lönnrot K, et al. Low plasma antioxidant activity is associated with high lesion volume and neurological impairment in stroke. Stroke 2000; 31(1): 33-39. (Pubitemid 30035749)
22. Ozkul A, Akyol A, Yenisey C, Arpaci E, Kiylioglu N, Tataroglu C. Oxidative stress in acute ischemic stroke. J Clin Neurosci 2007; 14(11): 1062-1066. (Pubitemid 47588935)
23. Demirkaya S, Topcuoglu MA, Aydin A, Ulas UH, Isimer AI, Vural O. Malondialdehyde, glutathione peroxidase and superoxide dismutase in peripheral blood erythrocytes of patients with acute cerebral ischemia. Eur J Neurol 2001; 8(1): 43-51. (Pubitemid 32154573)
24. Polidori MC, Cherubini A, Stahl W, Senin U, Sies H, Mecocci P. Plasma carotenoid and malondialdehyde levels in ischemic stroke patients: relationship to early outcome. Free Radic Res 2002; 36(3): 265-268. (Pubitemid 35154069)
25. Ghem C, Sarmento-Leite RE, de Quadros AS, Rossetto S, Gottschall CA. Serum bilirubin concentration in patients with an established coronary artery disease. Int Heart J 2010; 51(2): 86-91.
26. Oda E, Kawai R. A possible cross-sectional association of serum total bilirubin with coronary heart disease and stroke in a Japanese health screening population. Heart Vessels 2012; 27(1): 29-36.
27. Domínguez C, Delgado P, Vilches A, et al. Oxidative stress after thrombolysis-induced reperfusion in human stroke. Stroke 2010; 41(4): 653-660.